GlycoMimetics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of GlycoMimetics generated cash of -$34,879,903, which is more than the previous year. Cash used in financing activities reached the amount of $28,823,508 last year. Net change in cash is therefore -$6,077,789.
Cash Flow
| 2014 | -4.28M | -212.60K | 57.38M |
|---|---|---|---|
| 2015 | -8.24M | -268.59K | 114.12K |
| 2016 | -29.73M | -704.20K | 23.67M |
| 2017 | -29.76M | -294.10K | 113.94M |
| 2018 | -43.33M | -125.61K | 129.44M |
| 2019 | -51.98M | -144.92K | 412.91K |
| 2020 | -39.24M | -68.50K | 18.14M |
| 2021 | -57.48M | -14.94K | 10.72M |
| 2022 | -46.45M | -84.19K | 4.15M |
| 2023 | -34.87M | -21.39K | 28.82M |
GLYC Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 47.87M | 90.25M | 137.03M | 158.20M | 209.91M | 123.92M | 40.04M | 46.80M | 55.19M | 2.31M |
Operating activities | ||||||||||
Net income | -36.89M | -46.68M | -63.42M | -51.02M | -57.89M | -48.27M | -33.28M | -31.80M | -12.76M | -11.12M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 153.30K | 207.14K | 264.6K | 270.75K | 279.23K | 275.12K | 263.54K | 190.54K | 191.48K | 158.70K |
Stock-based compensation expense | 3.56M | 3.85M | 6.08M | 6.90M | 6.21M | 0 | 3.76M | 2.96M | 2.32M | 1.63M |
| Deferred income tax benefit | 3.56M | 3.85M | 6.08M | 6.90M | 6.21M | 0 | 3.76M | 2.96M | 2.32M | 1.63M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.69M | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 474.43K | 0 |
Accounts payable | -102.07K | -1.13M | 17.67K | 654.27K | -1.22M | 16.48K | 1.06M | 1.00M | -309.79K | -270.86K |
Cash generated by operating activities | -34.87M | -46.45M | -57.48M | -39.24M | -51.98M | -43.33M | -29.76M | -29.73M | -8.24M | -4.28M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -21.39K | -84.19K | -14.94K | -68.50K | -144.92K | -125.61K | -294.10K | -704.20K | -268.59K | -212.60K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -21.39K | -84.19K | -14.94K | -68.50K | -144.92K | -125.61K | -294.10K | -704.20K | -268.59K | -212.60K |
Financing activities | ||||||||||
Common Stock Issued | 28.70M | 4.15M | 10.69M | 17.82M | 412.91K | 128.42M | 113.57M | 23.60M | 114.12K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 28.82M | 4.15M | 10.72M | 18.14M | 412.91K | 129.44M | 113.94M | 23.67M | 114.12K | 57.38M |
Net Change In Cash | -6.07M | -42.38M | -46.78M | -21.16M | -51.71M | 85.99M | 83.88M | -6.76M | -8.39M | 52.88M |
Cash at end of period | 41.79M | 47.87M | 90.25M | 137.03M | 158.20M | 209.91M | 123.92M | 40.04M | 46.80M | 55.19M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |